Correlation Between Arrowhead Pharmaceuticals and SYSTEMAIR

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arrowhead Pharmaceuticals and SYSTEMAIR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrowhead Pharmaceuticals and SYSTEMAIR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arrowhead Pharmaceuticals and SYSTEMAIR AB, you can compare the effects of market volatilities on Arrowhead Pharmaceuticals and SYSTEMAIR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrowhead Pharmaceuticals with a short position of SYSTEMAIR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrowhead Pharmaceuticals and SYSTEMAIR.

Diversification Opportunities for Arrowhead Pharmaceuticals and SYSTEMAIR

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Arrowhead and SYSTEMAIR is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Arrowhead Pharmaceuticals and SYSTEMAIR AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SYSTEMAIR AB and Arrowhead Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrowhead Pharmaceuticals are associated (or correlated) with SYSTEMAIR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SYSTEMAIR AB has no effect on the direction of Arrowhead Pharmaceuticals i.e., Arrowhead Pharmaceuticals and SYSTEMAIR go up and down completely randomly.

Pair Corralation between Arrowhead Pharmaceuticals and SYSTEMAIR

Assuming the 90 days trading horizon Arrowhead Pharmaceuticals is expected to under-perform the SYSTEMAIR. In addition to that, Arrowhead Pharmaceuticals is 1.34 times more volatile than SYSTEMAIR AB. It trades about -0.01 of its total potential returns per unit of risk. SYSTEMAIR AB is currently generating about 0.05 per unit of volatility. If you would invest  424.00  in SYSTEMAIR AB on September 25, 2024 and sell it today you would earn a total of  352.00  from holding SYSTEMAIR AB or generate 83.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.8%
ValuesDaily Returns

Arrowhead Pharmaceuticals  vs.  SYSTEMAIR AB

 Performance 
       Timeline  
Arrowhead Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Arrowhead Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Arrowhead Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
SYSTEMAIR AB 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in SYSTEMAIR AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, SYSTEMAIR is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Arrowhead Pharmaceuticals and SYSTEMAIR Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arrowhead Pharmaceuticals and SYSTEMAIR

The main advantage of trading using opposite Arrowhead Pharmaceuticals and SYSTEMAIR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrowhead Pharmaceuticals position performs unexpectedly, SYSTEMAIR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SYSTEMAIR will offset losses from the drop in SYSTEMAIR's long position.
The idea behind Arrowhead Pharmaceuticals and SYSTEMAIR AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fundamental Analysis
View fundamental data based on most recent published financial statements